Market Overview:
The global Fenspiride market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type (tablets, syrup), by application (bronchitis, asthma, others) and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). The growth in the global Fenspiride market can be attributed to factors such as the increasing prevalence of respiratory diseases such as bronchitis and asthma; rising awareness about the benefits of using Fenspiride among patients; growing demand for generic drugs; and expanding distribution channels. However, factors such as high cost associated with branded drugs may restrain the growth of this market during the forecast period.
Product Definition:
Fenspiride is a long-acting, once-daily, oral anti-inflammatory drug used to treat asthma and chronic obstructive pulmonary disease (COPD). It relaxes the muscles in the airways and improves airflow. Fenspiride also helps to prevent asthma attacks.
Tablets:
Tablets are small square or rectangular shaped paper or plastic-coated tablets. They come in different sizes and shapes, but the size of the tablet is not important as long as it is crushed and divided into equal doses. The most common types of tablets used for OTC (over-the-counter) medications are film coated, enteric coated, effervescent, and disintegrating tablets.
Syrup:
Syrup is a liquid preparation used in the treatment of heart failure. It works by improving blood circulation and oxygen supply to the heart, which helps it to work normally. Syrup also reduces stress on the heart muscle caused due to insufficient blood flow, which further improves its functioning.
The product contains sugar and some minerals such as sodium chloride, potassium phosphate glucose solution (dextrose), and others are added for better results.
Application Insights:
The bronchitis segment held the largest share of over 50.0% in 2017. The rising prevalence of chronic bronchitis is expected to be a major factor for this growth during the forecast period. According to a research study, it is estimated that around 1 in 5 children suffer from asthma or chronic cough and about 2-3 million people die due to lung cancer every year globally. Therefore, increasing incidences of bronchitis are expected to boost product demand during the forecast period.
The others application segment includes emphysema and other respiratory diseases such as pneumonia and tuberculosis which will drive demand for fenspiride tablets over syrup owing to several advantages associated with its use such as faster onset action time, better patient compliance due lesser pill burden.
Regional Analysis:
Europe dominated the global market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the high prevalence of respiratory conditions, availability and promotion of advanced medicines, better healthcare facilities along with high disposable income and awareness about early diagnosis among people.
Asia Pacific is expected to be the fastest-growing region from 2018 to 2030 owing to increasing demand for affordable & accessible medicines, rising geriatric population prone to chronic diseases along with growing awareness about early diagnosis among people especially children & adolescents suffering from breathing problems such as asthma and bronchitis. In addition, increasing R&D activities by various companies will fuel growth over the forecast period.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for Fenspiride in the coming years.
- Growing awareness about the benefits of Fenspiride: There is a growing awareness among patients and healthcare professionals about the benefits of using Fenspiride for treating respiratory diseases. This is likely to boost demand for this drug in the coming years.
- Rising number of product approvals: The number of product approvals for Fenspiride has been rising in recent years, owing to its efficacy in treating respiratory diseases. This is likely to propel market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fenspiride Market Research Report
By Type
Tablets, Syrup
By Application
Bronchitis, Asthma, Others
By Companies
Kissei Pharmaceuticals, Hongxin Ruiyu Fine Chemical, Conscientia Industrial, AK Scientific, Emcure Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Fenspiride Market Report Segments:
The global Fenspiride market is segmented on the basis of:
Types
Tablets, Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bronchitis, Asthma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kissei Pharmaceuticals
- Hongxin Ruiyu Fine Chemical
- Conscientia Industrial
- AK Scientific
- Emcure Pharmaceuticals
Highlights of The Fenspiride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Syrup
- By Application:
- Bronchitis
- Asthma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fenspiride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fenspiride is a medication used to treat pulmonary hypertension (high blood pressure in the lungs). It works by relaxing the blood vessels in the lungs. This reduces blood pressure and improves breathing. Fenspiride is usually given as an injection once a day.
Some of the key players operating in the fenspiride market are Kissei Pharmaceuticals, Hongxin Ruiyu Fine Chemical, Conscientia Industrial, AK Scientific, Emcure Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fenspiride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fenspiride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fenspiride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fenspiride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fenspiride Market Size & Forecast, 2018-2028
4.5.1 Fenspiride Market Size and Y-o-Y Growth
4.5.2 Fenspiride Market Absolute $ Opportunity
Chapter 5 Global Fenspiride Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Fenspiride Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Syrup
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Fenspiride Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Fenspiride Market Size Forecast by Applications
6.2.1 Bronchitis
6.2.2 Asthma
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fenspiride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fenspiride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Fenspiride Analysis and Forecast
9.1 Introduction
9.2 North America Fenspiride Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Fenspiride Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Syrup
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Fenspiride Market Size Forecast by Applications
9.10.1 Bronchitis
9.10.2 Asthma
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Fenspiride Analysis and Forecast
10.1 Introduction
10.2 Europe Fenspiride Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Fenspiride Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Syrup
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Fenspiride Market Size Forecast by Applications
10.10.1 Bronchitis
10.10.2 Asthma
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Fenspiride Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Fenspiride Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Fenspiride Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Syrup
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Fenspiride Market Size Forecast by Applications
11.10.1 Bronchitis
11.10.2 Asthma
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Fenspiride Analysis and Forecast
12.1 Introduction
12.2 Latin America Fenspiride Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Fenspiride Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Syrup
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Fenspiride Market Size Forecast by Applications
12.10.1 Bronchitis
12.10.2 Asthma
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Fenspiride Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Fenspiride Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Fenspiride Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Syrup
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Fenspiride Market Size Forecast by Applications
13.10.1 Bronchitis
13.10.2 Asthma
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fenspiride Market: Competitive Dashboard
14.2 Global Fenspiride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kissei Pharmaceuticals
14.3.2 Hongxin Ruiyu Fine Chemical
14.3.3 Conscientia Industrial
14.3.4 AK Scientific
14.3.5 Emcure Pharmaceuticals
